multipl
bacteri
viral
pathogen
result
clinic
sign
canin
infecti
respiratori
diseas
complex
cirdc
coinfect
multipl
pathogen
commonli
identifi
clinic
diagnosi
cirdc
typic
made
histori
physic
examin
howev
etiolog
diagnosi
pursu
dog
sever
prolong
clinic
sign
diseas
outbreak
situat
clinic
sign
cirdc
typic
mild
selflimit
resolv
approxim
week
antimicrobi
treatment
warrant
dog
suspect
bacteri
pneumonia
optim
direct
base
bacteri
cultur
suscept
result
develop
pneumonia
rais
concern
underli
canin
distemp
viru
infect
underli
immunosuppress
diseas
vaccin
induc
steril
immun
therefor
comprehens
prevent
strategi
necessari
especi
grouphous
situat
canin
canin
influenza
viru
civ
report
advanc
molecular
identif
method
identifi
potenti
pathogen
may
play
role
diseas
complex
agent
associ
cirdc
transmit
via
aerosol
rout
frequent
caus
subclin
mild
upperrespiratori
sign
last
averag
week
sever
clinic
sign
note
dog
coinfect
multipl
cirdc
pathogen
secondari
bacteri
pneumonia
potenti
pathogen
involv
cirdc
discuss
includ
viral
bacteri
pathogen
see
tabl
prevent
measur
limit
spread
infect
avail
diagnost
treatment
option
b
bronchiseptica
worldwid
caus
respiratori
diseas
dog
also
caus
diseas
speci
includ
cat
pig
rabbit
peopl
differ
strain
gramneg
coccobacilli
like
vari
host
rang
abil
caus
diseas
isol
b
bronchiseptica
appar
healthi
dog
occur
transmiss
b
bronchiseptica
via
airborn
rout
highli
contagi
inhal
organ
adher
respiratori
cilia
way
adhes
molecul
fimbrial
adhes
filament
hemagglutinin
pertactin
lipopolysaccharid
organ
evad
host
defens
use
virul
factor
outer
capsul
antigen
protect
bacteria
phagocytosi
complement
mediat
attack
virul
factor
also
describ
includ
type
iii
secret
system
allow
bacteri
colon
adenyl
cyclas
toxin
antiinflammatori
immun
evas
properti
exotoxin
caus
necrosi
epitheli
cell
colon
establish
alter
respiratori
epitheli
cell
function
lead
excess
mucu
secret
impair
local
innat
immun
defens
predispos
host
infect
opportunist
secondari
pathogen
incub
period
b
bronchiseptica
rang
day
clinic
sign
vari
dramat
mild
upperrespiratori
tract
diseas
lead
mucopurul
nasal
discharg
sneez
cough
sever
diseas
case
involv
lowerrespiratori
tract
sign
system
ill
present
includ
lethargi
decreas
appetit
fever
product
cough
organ
shed
least
month
case
sever
month
mycoplasma
cyno
mani
mycoplasma
spp
commens
organ
colon
mucou
membran
respiratori
tract
role
canin
infecti
respiratori
diseas
clear
mycoplasma
spp
fastidi
organ
lack
cell
wall
smallest
known
freeliv
organ
isol
lung
trachea
healthi
adult
dog
cyno
mycoplasma
spp
significantli
associ
respiratori
diseas
dog
commonli
pneumonia
still
unclear
cyno
primari
secondari
pathogen
dog
cultur
lung
dog
without
identifi
infecti
respiratori
diseas
recent
associ
lethal
bronchopneumonia
litter
golden
retriev
puppi
coloni
laboratori
beagl
experiment
infect
dog
either
endobronchi
infect
exposur
infect
dog
result
develop
clinic
pneumonia
destruct
loss
respiratori
cilia
influx
neutrophil
macrophag
alveolu
younger
dog
like
infect
organ
compar
older
dog
dog
becom
infect
within
first
week
upon
enter
anim
shelter
cyno
persist
lung
week
follow
infect
canin
infecti
respiratori
diseas
transmit
via
aerosol
unknown
long
organ
persist
environ
howev
mycoplasma
spp
surviv
sever
week
outsid
host
therefor
assum
cyno
also
persist
environ
streptococcu
equi
subsp
zooepidemicu
bhemolyt
lancefield
group
c
streptococcu
emerg
caus
acut
sever
bronchopneumonia
dog
commens
organ
upperrespiratori
tract
hors
also
caus
opportunist
infect
abscess
endometr
result
abort
outbreak
sever
hemorrhag
pneumonia
describ
sever
popul
grouphous
dog
equi
subsp
zooepidemicu
identifi
caus
agent
histori
contact
hors
identifi
infect
dog
rare
equi
subsp
zooepidemicu
isol
dog
without
clinic
sign
dog
initi
mild
clinic
sign
includ
cough
nasal
discharg
howev
clinic
sign
rapidli
progress
within
hour
onset
result
develop
sever
acut
fibrinosuppur
necrot
hemorrhag
bronchopneumonia
pathogenesi
fulli
elucid
howev
bacteri
exotoxin
gene
identifi
equi
subsp
zooepidemicu
cours
clinic
diseas
dog
similar
streptococc
exotoxininduc
toxic
shock
syndrom
peopl
overzeal
host
immun
respons
induc
signific
patholog
condit
coinfect
pathogen
note
case
experiment
model
coinfect
equi
subsp
zooepidemicu
civ
result
sever
clinic
sign
wherea
infect
equi
subsp
zooepidemicu
alon
induc
diseas
bacteri
speci
isol
dog
cirdc
includ
streptococcu
cani
pasteurella
spp
pseudomona
spp
staphylococcu
spp
coliform
escherichia
coli
klebsiella
pneumonia
howev
like
repres
secondari
opportunist
infect
oppos
primari
pathogen
canin
genu
mastadenoviru
famili
adenovirida
nonenvelop
doublestrand
dna
viru
worldwid
caus
infecti
respiratori
diseas
dog
infect
noncili
bronchiolar
epitheli
cell
epitheli
cell
nasal
mucosa
pharynx
tonsillar
crypt
mucou
cell
trachea
bronchi
type
alveolar
epitheli
cell
clinic
sign
often
mild
consist
sneez
nasal
discharg
dri
cough
howev
sever
clinic
sign
observ
coinfect
cirdc
pathogen
present
viral
shed
typic
wane
week
infect
howev
viru
surviv
environ
week
month
canin
distemp
viru
cdv
genu
morbilliviru
famili
paramyxovirida
cdv
envelop
rna
viru
caus
myriad
clinic
sign
primarili
respiratori
variabl
gastrointestin
gi
neurolog
sign
cdv
highli
contagi
spread
aerosol
secret
viral
particl
initi
infect
monocyt
within
lymphoid
tonsillar
tissu
upperrespiratori
tract
dissemin
throughout
bodi
via
lymphat
cdv
also
infect
lymphocyt
particular
lymphocyt
caus
widespread
lymphocyt
destruct
lead
lymphopenia
first
day
infect
widespread
dissemin
multipl
organ
system
occur
clinic
sign
associ
cdv
infect
vari
subclin
infect
death
dog
present
respiratori
sign
consist
cird
also
gi
sign
ocular
discharg
neurolog
sign
andor
unknown
vaccin
histori
consid
high
risk
distemp
cdv
shed
bodili
secret
start
day
infect
shed
continu
month
viral
envelop
environment
surviv
sever
hour
routin
disinfect
inactiv
viru
canin
canid
envelop
doubledstrand
dna
viru
belong
famili
herpesvirida
major
clinic
syndrom
associ
reproduct
failur
bitch
sever
ill
neonat
also
isol
lung
tracheal
specimen
dog
rhiniti
pharyng
high
seropreval
note
dog
hous
kennel
situat
implic
cirdc
pathogen
experiment
infect
dog
lead
rhiniti
tracheobronch
ocular
sign
includ
kerat
conjunct
infect
epitheli
cell
upperrespiratori
mucosa
incub
period
day
like
herpesvirus
becom
latent
neurolog
tissu
reactiv
latent
infect
occur
consider
stress
pharmacolog
immunosuppress
intermitt
shed
respiratori
secret
throughout
life
patient
influenza
virus
segment
negativesens
rna
genom
envelop
civ
belong
famili
orthomyxovirida
genu
alphainfluenzaviru
influenza
subtyp
base
hemagglutinin
h
neuraminidas
n
gene
influenza
virus
infect
wide
varieti
anim
includ
bird
mammal
signific
genet
reassort
occur
multipl
subtyp
infect
singl
host
civ
caus
subtyp
influenza
adapt
spread
throughout
dog
popul
first
document
popul
race
greyhound
florida
viru
close
relat
equin
influenza
viru
subtyp
serosurvey
greyhound
indic
viru
first
emerg
canin
popul
viru
spread
throughout
countri
mostli
report
kennel
shelter
sporad
within
pet
popul
overal
preval
infect
declin
extinct
us
dog
popul
suspect
outbreak
civ
note
chicago
illinoi
caus
influenza
subtyp
genet
similar
strain
previous
report
south
east
asia
suspect
result
mutat
avian
influenza
viru
adapt
dog
sinc
strain
civ
spread
throughout
unit
state
reintroduct
asia
result
appear
addit
outbreak
civ
typic
caus
mild
clinic
respiratori
sign
includ
lethargi
cough
nasal
ocular
discharg
occasion
sever
clinic
sign
associ
pneumonia
clinic
sign
may
sever
infect
experiment
infect
civ
induc
necrot
hyperplast
tracheiti
canin
infecti
respiratori
diseas
bronchiti
dog
mild
bronchiol
pneumonia
dog
mani
dog
also
develop
secondari
bacteri
pneumonia
viral
shed
decreas
dramat
week
infect
howev
isol
dog
week
infect
canin
parainfluenza
viru
cpiv
envelop
singlestrand
negativesens
rna
viru
belong
famili
paramyxovirida
genu
rubulaviru
close
relat
simian
viru
cpiv
highli
contagi
caus
respiratori
diseas
dog
worldwid
introduct
vaccin
cpiv
could
isol
dog
respiratori
diseas
kennel
situat
cpiv
spread
via
respiratori
droplet
infect
occur
within
respiratori
epitheli
cell
dog
exhibit
clinic
sign
mild
clinic
sign
dri
harsh
cough
day
without
pyrexia
nasal
discharg
clinic
sign
appear
sever
coinfect
occur
experiment
infect
clinic
sign
respiratori
diseas
absent
mild
histolog
examin
show
rhiniti
mix
inflammatori
cell
infiltr
tracheobronch
bronchiol
loss
ciliat
respiratori
cell
epitheli
hyperplasia
viral
shed
decreas
week
infect
envelop
cpiv
render
suscept
inactiv
commerci
disinfect
canin
respiratori
coronaviru
crcov
group
coronaviru
famili
coronavirida
envelop
rna
viru
viru
first
describ
group
shelter
dog
respiratori
diseas
unit
kingdom
identifi
dog
worldwid
found
dog
without
clinic
sign
respiratori
diseas
infect
crcov
associ
mild
clinic
sign
includ
nasal
discharg
cough
sneez
experiment
crcov
infect
dog
result
mild
respiratori
diseas
viru
infect
respiratori
tissu
respiratori
associ
lymphoid
tissu
tonsil
local
lymph
node
infect
lymphoid
tissu
associ
histopatholog
chang
includ
damag
loss
respiratori
cilia
although
respiratori
tissu
appear
primari
site
viral
replic
crcov
also
detect
stool
intestin
dog
present
primari
respiratori
diseas
absenc
gi
sign
dog
coinfect
enter
viral
pathogen
absenc
respiratori
sign
viral
shed
detect
day
infect
molecular
techniqu
identifi
virus
dog
afflict
cirdc
pantrop
canin
coronaviru
group
coronaviru
strain
canin
enter
coronaviru
ccov
isol
group
dog
itali
sever
respiratori
diseas
strain
pantrop
ccov
associ
sever
clinic
diseas
puppi
less
month
age
compar
month
older
outbreak
report
throughout
europ
coinfect
canin
parvoviru
also
report
canin
pneumoviru
member
famili
paramyxovirida
infect
report
dog
anim
shelter
unit
state
respiratori
diseas
caus
agent
discov
virus
identifi
dog
respiratori
diseas
includ
canin
reoviru
canin
bocaviru
canin
hepaciviru
role
virus
induct
respiratori
diseas
unclear
investig
warrant
elucid
individu
role
cirdc
diagnosi
diseas
associ
cirdc
start
collect
histori
thorough
physic
examin
caus
agent
cirdc
short
incub
period
rang
day
week
histori
exposur
dog
often
present
agent
transmit
inhal
respiratori
droplet
although
fomit
transmiss
take
place
pathogen
dog
exhibit
mild
clinic
sign
paroxysm
harsh
cough
serou
ocular
discharg
nasal
discharg
andor
sneez
typic
energi
appetit
remain
normal
dog
exhibit
pyrexia
lethargi
decreas
appetit
sever
clinic
sign
like
secondari
bacteri
infect
complet
blood
count
serum
biochemistri
urinalysi
usual
normal
show
evid
inflamm
includ
mild
moder
neutrophilia
presenc
band
neutrophil
lymphopenia
thorac
radiograph
often
normal
mild
abnorm
rang
interstiti
bronchointerstiti
pulmonari
pattern
dog
sever
clinic
sign
secondari
bacteri
infect
alveolar
pulmonari
pattern
find
histori
physic
examin
blood
work
radiograph
rais
suspicion
diseas
caus
pathogen
within
cirdc
howev
etiolog
diagnosi
elucid
without
pathogenspecif
diagnost
assay
dog
sever
rapidli
progress
clinic
sign
clinic
sign
last
day
exist
outbreak
set
attempt
obtain
etiolog
diagnosi
recommend
bacteri
cultur
perform
specimen
obtain
nasal
swab
oropharyng
swab
tracheal
wash
bronchoalveolar
lavag
cultur
upperrespiratori
tract
interpret
caution
yield
growth
normal
flora
mani
cirdc
pathogen
b
bronchiseptica
isol
healthi
anim
isol
pathogen
multipl
anim
within
outbreak
set
would
like
meaning
collect
tracheal
wash
bronchoalveolar
lavag
specimen
indic
dog
sever
clinic
sign
evid
pneumonia
growth
cirdc
pathogen
b
bronchiseptica
cyno
dog
consist
clinic
sign
provid
support
involv
howev
coinfect
pathogen
still
consid
neg
test
result
rule
presenc
pathogen
cdv
growth
multipl
bacteri
speci
may
repres
opportunist
secondari
infect
contamin
fals
neg
occur
low
bacteri
burden
antimicrobi
administ
molecular
diagnost
assay
base
polymeras
chain
reaction
pcr
becom
wide
avail
commerci
laboratori
respiratori
panel
develop
use
realtim
pcr
detect
nucleic
acid
pathogen
includ
cpiv
cdv
crcov
chv
civ
b
bronchiseptica
mycoplasma
spp
swab
nasal
caviti
oropharyng
caviti
specimen
collect
lowerrespiratori
tract
submit
pcr
fals
neg
result
common
transient
lowlevel
shed
sampl
degrad
transit
laboratori
vaccin
within
previou
week
liveattenu
vaccin
lead
fals
posit
result
viru
isol
increasingli
replac
pcr
assay
still
offer
special
virolog
laboratori
eg
anim
health
diagnost
laboratori
cornel
univers
ithaca
ny
usa
swab
upperrespiratori
tract
specimen
collect
lowerrespiratori
tract
submit
viru
isol
suffer
pitfal
pcr
fals
neg
low
intermitt
viral
shed
degrad
viru
particl
transit
possibl
laboratori
contact
advanc
specimen
collect
provid
instruct
storag
transport
condit
collect
specimen
serolog
assay
measur
antibodi
cirdc
viral
pathogen
avail
howev
clinic
use
limit
antibodi
occur
respons
vaccin
distinguish
produc
owe
infect
subclin
infect
treatment
treatment
dog
uncompl
sign
cirdc
typic
involv
support
care
clinic
sign
dog
resolv
without
treatment
clinic
sign
present
less
week
dog
bright
good
appetit
specif
therapi
recommend
current
guidelin
expector
medic
guaifenesin
shown
benefici
reduc
clinic
sign
cirdc
therefor
recommend
use
cough
suppress
consid
order
provid
relief
affect
dog
owner
especi
cough
persist
week
occur
throughout
night
overthecount
antituss
medic
might
somewhat
effect
dog
mild
clinic
sign
narcot
antituss
hydrocodon
effect
reduc
clinic
sign
howev
administr
contraind
anim
product
cough
diminish
clearanc
bacteria
administ
predispos
secondari
infect
current
label
antivir
therapi
dog
cirdc
publish
recommend
administr
commerci
avail
influenza
antivir
use
human
medicin
therefor
antivir
therapi
recommend
dog
clinic
sign
persist
beyond
week
sign
bacteri
pneumonia
pyrexia
lethargi
decreas
appetit
alveolar
pulmonari
pattern
thorac
radiograph
treat
antimicrobi
ideal
treatment
bacteri
pathogen
b
bronchiseptica
opportunist
secondari
pathogen
guid
cultur
suscept
test
antimicrobi
resist
increasingli
recogn
especi
among
bordetella
isol
empir
antimicrobi
therapi
base
like
agent
present
doxycyclin
recommend
dog
suspect
b
bronchiseptica
cyno
infect
bacteri
infect
suspect
secondari
underli
viral
infect
broadspectrum
antimicrobi
appropri
sever
case
parenter
antimicrobi
combin
includ
fluoroquinolon
penicillin
clindamycin
recommend
addit
support
care
advis
tailor
patient
need
addit
support
care
includ
hydrat
andor
nutrit
support
oxygen
therapi
nebul
coupag
care
taken
prevent
irrit
trachea
avoid
neck
lead
remov
bark
trigger
vaccin
avail
mani
common
cirdc
pathogen
see
tabl
cdv
cpiv
civ
b
bronchiseptica
except
cdv
vaccin
produc
steril
immun
rather
decreas
sever
clinic
sign
magnitud
pathogen
shed
cdv
vaccin
core
vaccin
administ
dog
remain
vaccin
recommend
dog
risk
exposur
mucos
administ
intranas
transor
parenter
vaccin
avail
cpiv
b
bronchiseptica
rout
vaccin
deliveri
pathogen
impact
immun
respons
debat
literatur
intranas
intraor
vaccin
recommend
improv
mucos
immun
respons
permit
rapid
onset
protect
overcrowd
environ
shelter
howev
mucos
vaccin
sometim
result
vaccineinduc
diseas
difficult
know
whether
diseas
shelter
environ
secondari
vaccin
natur
infect
concern
also
rais
intranas
vaccin
strain
b
bronchiseptica
might
capabl
caus
human
diseas
immunosuppress
although
molecular
evid
lack
vaccin
intranas
vaccin
follow
develop
low
titer
serum
immunoglobulin
g
igg
wherea
serum
igg
respons
higher
parenter
vaccin
recent
studi
suggest
intranas
vaccin
may
provid
greater
clinic
protect
challeng
oral
vaccin
addit
studi
warrant
assess
optim
vaccin
type
dog
parenter
vaccin
avail
reduct
clinic
sign
owe
civ
includ
individu
vaccin
combin
bival
vaccin
commerci
avail
vaccin
avail
reduct
clinic
sign
caus
crcov
chv
although
vaccin
major
prevent
strategi
precaut
must
taken
immun
protect
infect
grouphous
situat
precautionari
measur
includ
isol
period
dog
enter
popul
rigor
daili
monitor
develop
clinic
sign
within
group
quarantin
protocol
dog
clinic
sign
associ
cirdc
care
taken
prevent
overcrowd
stress
within
popul
outbreak
occur
facil
infecti
diseas
protocol
place
limit
exposur
dog
facil
isol
ill
anim
popul
larg
appli
proper
disinfect
protocol
attempt
made
determin
etiolog
agent
target
prevent
treatment
protocol
institut
contagi
respiratori
diseas
pervas
problem
grouphous
dog
pet
comingl
dog
molecular
techniqu
led
discoveri
cirdc
pathogen
previous
associ
diseas
complex
highlight
import
coinfect
diseas
sever
increas
travel
dog
around
world
like
novel
pathogen
continu
emerg
civ
variant
past
decad
specif
therapi
avail
viral
cirdc
pathogen
avail
vaccin
convey
steril
immun
prevent
infect
vital
grouphous
dog
dr
je
syke
receiv
honoraria
research
fund
boehring
ingelheim
zoeti
elanco
merck
idexx
laboratori
